Related Experiment Video

Updated: Jun 6, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in

Massimo Squatrito1, Cameron W Brennan, Karim Helmy

  • 1Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Cancer Cell
|December 16, 2010
PubMed

Insights

The DNA-damage response (DDR) pathway suppresses glioma formation by maintaining genomic integrity. Its loss accelerates tumor growth, highlighting its tumor suppressor role in brain cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Genomic integrity is crucial for tissue health; DNA-damage response (DDR) defects are implicated in various diseases, including cancer.
  • The role of DDR in glioma, a type of brain tumor, is not fully understood.

Purpose of the Study:

  • To investigate the tumor suppressor activity of the DDR in gliomas.
  • To determine the impact of DDR alterations on glioma development and response to therapy.

Main Methods:

  • Analysis of DDR gene alterations in human glioma samples.
  • Utilizing a glioma mouse model to study the effects of DDR component loss on tumor formation.
  • Assessing the role of Chk2 in glioma response to ionizing radiation in vivo.
  • Investigating DNA-damage checkpoints in neuronal stem cells.

Main Results:

  • Genes in the DDR pathway are frequently altered in human gliomas.
  • Loss of ATM/Chk2/p53 cascade components accelerates glioma formation in mice.
  • Chk2 is essential for glioma response to ionizing radiation and DNA-damage checkpoints in neuronal stem cells.
  • Constitutive DDR activation is observed in a subset of glioblastoma multiforme (GBM) cases, correlating with hypoxic regions.

Conclusions:

  • The DNA-damage response (DDR) pathway exhibits tumor suppressor activity in gliomas.
  • Alterations in DDR genes contribute to glioma development.
  • Chk2 plays a critical role in glioma radiosensitivity and neuronal stem cell DNA-damage response.
  • DDR activation in GBM may be linked to tumor microenvironment factors like hypoxia.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...